Tau pathology, neuroinflammation, and neurodegeneration are key aspects of Alzheimer’s
disease. Understanding whether these features predict cognitive decline, alone or in …

Animal studies suggest that the apolipoprotein E ε4 (APOEε4) allele is a culprit of early
microglial activation in Alzheimer’s disease (AD). Here, we tested the association between …

Background Neurodegeneration in the locus coeruleus (LC) contributes to neuropsychiatric
symptoms in both Parkinson's disease (PD) and progressive supranuclear palsy (PSP). …

Cognitive reserve (CR) prevents cognitive decline and delays neurodegeneration. Recent
epidemiological evidence suggests that lifelong bilingualism may act as CR delaying the …

Objectives This longitudinal study compared emerging plasma biomarkers for neurodegenerative
disease between controls, patients with Alzheimer’s disease (AD), Lewy body …

Cognitive reserve (CR) and brain reserve (BR) are protective factors against age‐associated
cognitive decline and neurodegenerative disorders. Very limited evidence exists about …

Frontotemporal dementia is clinically and neuropathologically heterogeneous, but
neuroinflammation, atrophy and cognitive impairment occur in all of its principal syndromes. Across …

Background Synaptic loss is a prominent and early feature of many neurodegenerative
diseases. Objectives We tested the hypothesis that synaptic density is reduced in the primary …

Background Synaptic loss is characteristic of many neurodegenerative diseases; it occurs
early and is strongly related to functional deficits. Objective In this longitudinal observational …

Objective Synaptic loss is an early feature of neurodegenerative disease models, and is
severe in post mortem clinical studies, including frontotemporal dementia. Positron emission …